FGFR3 is expressed by human primordial germ cells and is repressed after meiotic initiation to form primordial oocytes

Stem Cell Reports. 2022 Jun 14;17(6):1268-1278. doi: 10.1016/j.stemcr.2022.04.015. Epub 2022 May 19.

Abstract

Human germ cell development is a highly regulated process beginning soon after embryo implantation with the specification of primordial germ cells (PGCs) and ending in adulthood with the differentiation of gametes. Here, we show that fibroblast growth factor receptor 3 (FGFR3) is expressed by human PGCs during the first and second trimester, becoming repressed as PGCs differentiate into primordial oocytes. Using fluorescence-activated cell sorting (FACS) with antibodies that recognize FGFR3 followed by single-cell RNA sequencing, we show that isolating FGFR3-positive cells enriches for human PGCs. Taken together, FGFR3 could be used in future studies as a strategy to identify maturing PGCs in vitro.

Keywords: FACS; FGFR3; PGCLCs; embryonic ovaries; embryonic testes; germ cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell Differentiation
  • Flow Cytometry
  • Germ Cells*
  • Humans
  • Oocytes
  • Receptor, Fibroblast Growth Factor, Type 3* / genetics
  • Receptor, Fibroblast Growth Factor, Type 3* / metabolism

Substances

  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3